| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.10B | 11.94B | 10.80B | 10.36B | 9.06B | 6.71B |
| Gross Profit | 3.41B | 3.66B | 3.21B | 2.99B | 2.70B | 1.87B |
| EBITDA | 1.25B | 1.21B | 1.17B | 1.02B | 1.09B | 638.86M |
| Net Income | 649.09M | 573.34M | 589.09M | 518.07M | 651.48M | 413.84M |
Balance Sheet | ||||||
| Total Assets | 6.24B | 6.73B | 6.51B | 5.39B | 4.13B | 2.94B |
| Cash, Cash Equivalents and Short-Term Investments | 2.19B | 2.36B | 1.94B | 1.76B | 1.54B | 1.36B |
| Total Debt | 1.78B | 1.52B | 1.61B | 997.22M | 172.75M | 204.02M |
| Total Liabilities | 3.13B | 3.10B | 3.25B | 2.57B | 1.72B | 1.23B |
| Stockholders Equity | 3.11B | 3.63B | 3.26B | 2.82B | 2.41B | 1.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 856.27M | 481.11M | 293.57M | 729.10M | 461.95M |
| Operating Cash Flow | 0.00 | 934.84M | 603.23M | 457.63M | 846.96M | 505.34M |
| Investing Cash Flow | 0.00 | -234.09M | -865.66M | -859.53M | -639.67M | -104.26M |
| Financing Cash Flow | 0.00 | -281.45M | 439.16M | 625.08M | -29.44M | -235.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥29.91B | 9.69 | ― | 2.93% | 7.86% | 28.33% | |
71 Outperform | ¥21.43B | 10.82 | ― | 1.70% | 15.21% | 12.50% | |
70 Outperform | ¥43.10B | 10.08 | 17.50% | 2.88% | 4.87% | 3.91% | |
64 Neutral | ¥16.46B | 15.75 | ― | 2.36% | -2.06% | 87.60% | |
63 Neutral | ¥8.54B | 8.30 | ― | 0.95% | 10.61% | -1.13% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
45 Neutral | ¥10.54B | -0.86 | ― | 5.03% | -6.49% | -402.49% |